skip to content

At-a-Glance

Issue No. 31 | December 31, 2015

News and Features

FDA Updates Saquinavir Labeling

“FDA approved changes to the Invirase (saquinavir mesylate) label to provide update[s] for drugs that are contraindicated or interact with Invirase/ritonavir."

“Also a warning was added to state cobicistat is not recommended for concomitant use with Invirase.”

The updated labeling will be available at the FDA website.

More information is available:

Recent HIV/AIDS News from FDA and NIAID

From FDA:

From NIAID: